These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations. Arya VB; Guemes M; Nessa A; Alam S; Shah P; Gilbert C; Senniappan S; Flanagan SE; Ellard S; Hussain K Eur J Endocrinol; 2014 Dec; 171(6):685-95. PubMed ID: 25201519 [TBL] [Abstract][Full Text] [Related]
7. The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-dopa positron emission tomography. Hussain K; Seppänen M; Näntö-Salonen K; Adzick NS; Stanley CA; Thornton P; Minn H J Clin Endocrinol Metab; 2006 Aug; 91(8):2839-42. PubMed ID: 16684819 [TBL] [Abstract][Full Text] [Related]
8. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819 [TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinism in the Neonate. Lord K; De León DD Clin Perinatol; 2018 Mar; 45(1):61-74. PubMed ID: 29406007 [TBL] [Abstract][Full Text] [Related]
10. The heterogeneity of focal forms of congenital hyperinsulinism. Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516 [TBL] [Abstract][Full Text] [Related]
11. Rapid genetic analysis, imaging with 18F-DOPA-PET/CT scan and laparoscopic surgery in congenital hyperinsulinism. Cherubini V; Bagalini LS; Ianilli A; Marigliano M; Biagioni M; Carnielli V; Iasonni V; Berbellini A; Hussain K; Gabrielli O J Pediatr Endocrinol Metab; 2010; 23(1-2):171-7. PubMed ID: 20432820 [TBL] [Abstract][Full Text] [Related]
12. Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. Stanley CA J Clin Endocrinol Metab; 2016 Mar; 101(3):815-26. PubMed ID: 26908106 [TBL] [Abstract][Full Text] [Related]
13. Congenital Hyperinsulinism Caused by Mutations in Butnariu LI; Bizim DA; Păduraru G; Păduraru L; Moisă ȘM; Popa S; Gimiga N; Ghiga G; Bădescu MC; Lupu A; Vasiliu I; Trandafir LM Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791571 [TBL] [Abstract][Full Text] [Related]
14. A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism. Palladino AA; Stanley CA Semin Pediatr Surg; 2011 Feb; 20(1):32-7. PubMed ID: 21186002 [TBL] [Abstract][Full Text] [Related]
15. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia. Banerjee I; Salomon-Estebanez M; Shah P; Nicholson J; Cosgrove KE; Dunne MJ Diabet Med; 2019 Jan; 36(1):9-21. PubMed ID: 30246418 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Otonkoski T; Näntö-Salonen K; Seppänen M; Veijola R; Huopio H; Hussain K; Tapanainen P; Eskola O; Parkkola R; Ekström K; Guiot Y; Rahier J; Laakso M; Rintala R; Nuutila P; Minn H Diabetes; 2006 Jan; 55(1):13-8. PubMed ID: 16380471 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism. Yorifuji T; Kawakita R; Hosokawa Y; Fujimaru R; Matsubara K; Aizu K; Suzuki S; Nagasaka H; Nishibori H; Masue M Clin Endocrinol (Oxf); 2013 Jun; 78(6):891-7. PubMed ID: 23067144 [TBL] [Abstract][Full Text] [Related]
18. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. Adzick NS; Thornton PS; Stanley CA; Kaye RD; Ruchelli E J Pediatr Surg; 2004 Mar; 39(3):270-5. PubMed ID: 15017536 [TBL] [Abstract][Full Text] [Related]
19. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism. Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349 [TBL] [Abstract][Full Text] [Related]
20. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. Henquin JC; Nenquin M; Sempoux C; Guiot Y; Bellanné-Chantelot C; Otonkoski T; de Lonlay P; Nihoul-Fékété C; Rahier J J Clin Invest; 2011 Oct; 121(10):3932-42. PubMed ID: 21968111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]